Jonathan A. Gutman

University of Colorado at Denver - Division of Hematology

13001 E 17th Pl

Aurora, CO 80045

United States

SCHOLARLY PAPERS

1

DOWNLOADS

2

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (1)

1.

Sequential Azacitidine and Lenalidomide for Patients with Relapsed and Refractory Acute Myeloid Leukemia: Clinical Results and Predictive Modeling Using Computational Analysis

Number of pages: 82 Posted: 04 Jan 2019
University of Colorado at Denver - Division of Hematology, University of Colorado at Denver - Children’s Hospital Colorado, University of Colorado at Denver - Division of Hematology, University of Colorado at Denver - Division of Hematology, University of Colorado at Denver - Division of Hematology, University of Colorado at Denver - Children’s Hospital Colorado, University of Colorado at Denver - Children’s Hospital Colorado, University of Colorado at Denver - Children’s Hospital Colorado, Cellworks Group Inc., Cellworks Group Inc., Cellworks Group Inc., University of Florida, University of Florida, University of Colorado at Denver, University of Colorado at Denver - Department of Emergency Medicine, University of Colorado at Denver - Division of Hematology, University of Colorado at Denver - Division of Hematology and University of Colorado at Denver - Division of Hematology
Downloads 2 (644,842)

Abstract:

Loading...

acute myeloid leukemia, myelodysplastic syndrome, relapsed, azacitidine, lenalidomide, phase 2